Surface Oncology, Inc. (14) | License Agreements (3)
Amendment No. 1, dated as of August 11, 2021, to License Agreement, dated as of December 16, 2020, by and between Surface Oncology, In.c and GLAXOSMITHKLINE INTELLECTUAL PROPERTY...
(Filed With SEC on November 4, 2021)
Exclusive Product License Agreement, dated March 23, 2021, by and between Vaccinex, Inc. and Surface Oncology, Inc
(Filed With SEC on May 5, 2021)
License Agreement, dated as of December 16, 2020, by and between the Company and GLAXOSMITHKLINE INTELLECTUAL PROPERTY (No. 4) LIMITED
(Filed With SEC on December 17, 2020)